Not exact matches
«FDA's approach to
evaluation of recent hepatitis C drugs underscores the Agency's flexibility in considering innovative or alternative trial designs for drugs that have demonstrated highly promising outcomes in early phase development,» said Dr. Poonam Mishra, deputy director for Safety, Division of Antiviral Products / Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research and lead author of the Hepatol
evaluation of recent hepatitis C drugs underscores the Agency's flexibility in considering innovative or alternative trial designs for drugs that have demonstrated highly promising outcomes in
early phase development,» said Dr. Poonam Mishra, deputy director for Safety, Division of Antiviral Products / Office of Antimicrobial Products in the FDA's Center for Drug
Evaluation and Research and lead author of the Hepatol
Evaluation and Research and lead author of the Hepatology paper.
A
Phase I
evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with
early human immunodeficiency virus infection.
The Johns Hopkins Kimmel Cancer Center is one of 11 Lead Academic Organization sites of the National Cancer Institute's Experimental Therapeutics Clinical Trials Network (ETCTN), which supports the
evaluation of
early phase clinical trials on experimental therapies.
We are currently engaged in the next
phase of this
evaluation: an analysis of
early academic impacts.
We've done a technical
evaluation of Bitcoin Gold and determined that it is still
early in its software development
phase.
Transforming Systems for Parental Depression and
Early Childhood Developmental Delays: Findings and Lessons Learned From the Helping Families Raise Healthy Children Initiative (PDF - 1,567 KB) Schultz, Reynolds, Sontag - Padilla, Lovejoy, Firth, & Pincus (2013) RAND Corporation Discusses the findings of an
evaluation of the Helping Families Raise Healthy Children initiative, the fourth
phase of the Allegheny County Maternal and Child Health Care Collaborative's efforts to implement changes in the local system of maternal and child health care.
The
evaluation of the
early effects (short - run) of SSLP found mixed effects, with beneficial effects for some groups, but adverse effects for children from families with higher needs and experiencing greater disadvantage.3 Results from the second
phase of the
evaluation were more positive.
The size of the CfC impacts on most outcomes was small, but can be considered positive relative to what was observed in the
early phase of the UK Sure Start
evaluation.3 The current results are also comparable in size to those found in the later impact
evaluation of the Sure Start programme, in which 3 - year - old children were exposed to mature SSLP throughout their entire lives.4 Reviews of the effectiveness of
early childhood interventions have found that most studies reported effect sizes on parenting and child outcomes that were small to moderate.14 15 When comparing CfC and SSLP with other interventions, it is important to remember that the
evaluations of these interventions measured effects on an entire population, rather than on programme participants, as is the case in the
evaluation of many other interventions.